SCHEDULE: FMR LLC & Abigail Johnson Maintain 10.1% Stake in LifeStance Health
Beneficial Ownership Amendment
FMR LLC and Abigail P. Johnson report a continued 10.1% beneficial ownership in LifeStance Health Group Inc. common stock.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 39,249,054.02 shares of LifeStance Health Group Inc. common stock.
- This ownership represents 10.1% of the total outstanding common stock of LifeStance Health Group Inc.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of the issuer.
- FMR LLC holds sole voting power over 39,239,105.00 shares and sole dispositive power over 39,249,054.02 shares.
- Abigail P. Johnson, as a control person of FMR LLC, is also deemed to beneficially own the same aggregate amount of shares with sole dispositive power.
- This filing is an Amendment No. 7 to a Schedule 13G, indicating an update to previous ownership disclosures.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine ownership disclosure (Schedule 13G/A) and does not contain performance or strategic updates. The continued significant stake by a major institutional investor is a stable, rather than overtly positive or negative, signal.
Positives
- A significant institutional investor, FMR LLC, maintains a substantial 10.1% stake in LifeStance Health Group Inc., which can signal continued confidence in the company.
Future Outlook
The filing does not provide forward-looking statements or guidance regarding LifeStance Health Group Inc.'s operations or financial performance.
Industry Context
This filing reflects a significant institutional investor's continued stake in a publicly traded healthcare company specializing in mental health services. Such Schedule 13G filings are routine disclosures of ownership percentages and do not typically provide operational or strategic insights into the issuer's industry position or competitive landscape.
Stakeholder Impact
- Shareholders: Provides transparency on a significant institutional holding, potentially offering a degree of stability or confidence in the company's long-term prospects.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC where Power of Attorney was incorporated by reference. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC where Abigail P. Johnson's Power of Attorney was incorporated by reference. |
| 2025-10-31 | Date of event which requires filing of this statement. |
| 2025-11-06 | Date of joint filing agreement and signatures for this Schedule 13G/A. |
Recommendation
holdThis Schedule 13G/A filing is a routine disclosure of beneficial ownership by a major institutional investor, FMR LLC, and its control person, Abigail P. Johnson. It indicates a continued 10.1% stake in LifeStance Health Group Inc. The filing itself does not contain new financial performance data, strategic updates, or material changes in ownership that would warrant a change in investment recommendation. The maintenance of a significant stake by a reputable institutional investor can be seen as a neutral to slightly positive signal of long-term interest, but without further operational or financial information, a 'hold' recommendation is appropriate as there's no new information to drive a 'buy' or 'sell' decision.
Keywords
LifeStance Health Group Inc, Lifestance, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Institutional Investment, Common Stock, Healthcare, Mental Health Services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.